You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PROMETA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Prometa, and when can generic versions of Prometa launch?

Prometa is a drug marketed by Muro and is included in two NDAs.

The generic ingredient in PROMETA is metaproterenol sulfate. There are six drug master file entries for this compound. Additional details are available on the metaproterenol sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Prometa

A generic version of PROMETA was approved as metaproterenol sulfate by GENUS on July 22nd, 1992.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROMETA?
  • What are the global sales for PROMETA?
  • What is Average Wholesale Price for PROMETA?
Summary for PROMETA
Drug patent expirations by year for PROMETA
Recent Clinical Trials for PROMETA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Institute of Addiction MedicineN/A
University of California, Los AngelesPhase 2/Phase 3
Medical University of South CarolinaPhase 2/Phase 3

See all PROMETA clinical trials

US Patents and Regulatory Information for PROMETA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Muro PROMETA metaproterenol sulfate SOLUTION;INHALATION 073340-001 Mar 30, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Muro PROMETA metaproterenol sulfate SYRUP;ORAL 072023-001 Sep 15, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.